• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 PER-Q-CATH PLUS 4F SINGLE-LUMEN PICC W/SAFETY EXCALIBUR INTRODUCER; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 PER-Q-CATH PLUS 4F SINGLE-LUMEN PICC W/SAFETY EXCALIBUR INTRODUCER; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Thrombosis/Thrombus (4440); Swelling/ Edema (4577)
Date of Event 12/08/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2021, due to the need for chemotherapy, a peripherally intubated central venous catheter was used to insert the central venous catheter from the right upper extremity into the superior vena cava under the guidance of b-ultrasound for intravenous infusion of drugs to prevent extravasation of chemotherapy drugs.After the catheter is placed, the catheter should be sterilized, changed, and cleaned every week for maintenance.For chemotherapy: 2 cycles of endostatin therapy on (b)(6) 2021 and (b)(6) 2021, 2 cycles of chemotherapy starting on (b)(6) 2021, and (b)(6) 2021, the specific dose is: more sitaxel + carboplatin.For the treatment of lung cancer.On (b)(6) 2021, he was returned to the hospital and the patient complained of swelling, pain and discomfort in the right upper arm.The b-ultrasound of the right upper extremity vein showed thrombosis of the right subclavian vein indwelling tube.After consultation with vascular surgery, oral rivaroxaban 10 mg was added on (b)(6) 2021, once a day for anticoagulation.
 
Additional Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) review is not possible, as no manufacturing lot number has been provided by the complainant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PER-Q-CATH PLUS 4F SINGLE-LUMEN PICC W/SAFETY EXCALIBUR INTRODUCER
Common Device Name
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
johanna de oliveira
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key13373043
Report Number3006260740-2022-00090
Device Sequence Number3263298
Product Code LJS
UDI-Device Identifier00801741074899
UDI-Public(01)00801741074899
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K954104
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/31/2023
Device Model NumberN/A
Device Catalogue Number4134115
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/06/2022
Initial Report FDA Received Date01/27/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-